Product Description
| Cat Number | HB185026 |
|---|---|
| Category | Biosimilar |
| Pack Size | 100 ug |
| Description | Lintuzumabisahumanizedmonoclonalantibody,HuM195,thattargetsthecellsurfaceantigenCD33thatisexpressedonthevastmajorityofacutemyeloidleukemia(AML)cells.[225Ac]Ac-lintuzumabclinicaltrialswerediscussedindetailinreference.LintuzumabisunderinvestigationinclinicaltrialNCT00016159(ChemotherapyPlusMonoclonalAntibodyinTreatingPatientsWithAcutePromyelocyticLeukemia). |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target | MyeloidcellsurfaceantigenCD33,Sialicacid-bindingIg-likelectin3,Siglec-3,CD33,gp67,SIGLEC3 |
| Clonality | Monoclonal |
| Synonyms | 225Ac-lintuzumab,HuM195,SGN-33,SMARTM195,HuM195,CAS:166089-32-3 |
| Host | Humanized |
| Concentration | 1.39mg/ml |
| Isotype | IgG1-kappa |
| Form | Liquid |
| Purity | >95% as determined by SDS-PAGE. |
| Specie Reactivity | Human |
| Storage | 0.01M PBS, pH7.4. |
| Note | The product is for research use only |
Share Item: